PM360 Trailblazer Finalist 2016
We are proud to have been named Finalist for the PM360 Trailblazer Awards in two categories: the Digital Solution category for the IPF Educational Portal and the HCP Initiative Category for the IPF Digital Initiative
And the winner is….
Pharmaceutical Market Excellence Awards, Winner Category: "Rare Diseases and Orphan Drugs" For the IPF Digital Initiative – a combination of several customer and patient-centric education and support programmes developed by infill healthcare communication for Boehringer Ingelheim GmbH. Judges' comment: “Boehringer Ingelheim carried out detailed research into this rare…
Supporting children in Dicou – ‘our village’ in Haiti
Healthcare is very close to our hearts, it is at the core of our business and the centre of our corporate social responsibility approach Studies show that health is most effectively improved through education(1),(2), even more so than via research and medical therapy. Educating children and families about healthcare, nutrition and hygiene encourages…
Mastering the rare disease challenge
Orphan drugs are few and far between. Long awaited by patients and physicians it should be an easy job to market them. However, diagnosis comes before treatment and with more than 6,000 rare diseases prevalent in Europe alone, it is little surprising that physicians are vague on specifics. Clinicians have…
Reasons to go digital
Reasons to go digital Why virtual healthcare marketing makes a lot of sense It’s true that in the heavily regulated healthcare industry, e-commercialisation has been slower to gain a foothold than in other industries. However, while pharmaceutical companies are still debating how to plough the virtual space, patients have stolen…